Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro
Abstract The essential role of RIPK3 in necroptosis makes its inhibition a promising therapeutic strategy. However, the development of RIPK3 inhibitors has been hampered by on-target apoptosis and limited kinase selectivity. Inspired by the R69H mutation, which prevents on-target apoptosis by disrup...
Saved in:
| Main Authors: | Haixia Su, Guofeng Chen, Hang Xie, Wanchen Li, Muya Xiong, Jian He, Hangchen Hu, Wenfeng Zhao, Qiang Shao, Minjun Li, Qiang Zhao, Yechun Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59432-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS
by: Wenfeng Zhao, et al.
Published: (2025-06-01) -
Dynamic Cap‐Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease
by: Haixia Su, et al.
Published: (2025-07-01) -
Targeting the RAGE–RIPK1 binding site attenuates diabetes-associated cognitive deficits
by: Lin Gao, et al.
Published: (2025-06-01) -
AQP1 Affects Necroptosis by Targeting RIPK1 in Endothelial Cells of Atherosclerosis
by: Wang P, et al.
Published: (2025-03-01) -
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
by: Yong Chen, et al.
Published: (2025-07-01)